ERN1 and Alzheimer disease: IRE1 signaling was considered to be pathogenic in ALS (Montibeller and de Belleroche, 2018), Alzheimer’s disease (AD) (Duran-Aniotz et al., 2017) and PD (Yan et al., 2019).